Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odile Launay

Showing results (201-210 of 305) with videos related to

Pageof 31
Sort By:
The Journal of Rheumatology|February 19, 2013
Influence of environmental factors on disease activity in spondyloarthritis: a prospective cohort studyNadine Zeboulon-Ktorza, Pierre Yves Boelle, Roula Said Nahal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2008
Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC studyOdile Launay, Sophie Grabar, Emmanuel Gordien, et al.
Vaccines|July 2, 2021
Immunization Catch-Up for Newly Arrived Migrants in France: A Cross-Sectional Study among French General PractitionersSohela Moussaoui, Anne Marie Aurousseau, Sylvain Nappez, et al.
Antiviral Therapy|November 18, 2009
A population analysis of weight-related differences in lopinavir pharmacokinetics and possible consequences for protease inhibitor-naive and -experienced patientsMarion Bouillon-Pichault, Vincent Jullien, Christophe Piketty, et al.
Influenza and Other Respiratory Viruses|November 17, 2025
Relative Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccines in Preventing Hospitalizations: A National Retrospective Cohort Study in France, 2022/2023 SeasonHélène Bricout, Marie-Cécile Levant, Pascal Crépey, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2024
The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-2022 influenza seasonHélène Bricout, Marie-Cécile Levant, Nada Assi, et al.
The Journal of Clinical Investigation|March 8, 2019
Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccinationEléna Gonçalves, Olivia Bonduelle, Angèle Soria, et al.
Human Vaccines|February 18, 2009
Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendationsOdile Launay, Christine Toneatti, Claire Bernède, et al.
Arthritis Care & Research|April 5, 2013
Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort studySolen Kernéis, Odile Launay, Thierry Ancelle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2021
Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?Caroline Papeix, Julie Mazoyer, Elisabeth Maillart, et al.
Pageof 31

Showing results (201-210 of 305) with videos related to

Sort By:
Pageof 31
The Journal of Rheumatology|February 19, 2013
Influence of environmental factors on disease activity in spondyloarthritis: a prospective cohort studyNadine Zeboulon-Ktorza, Pierre Yves Boelle, Roula Said Nahal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2008
Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC studyOdile Launay, Sophie Grabar, Emmanuel Gordien, et al.
Vaccines|July 2, 2021
Immunization Catch-Up for Newly Arrived Migrants in France: A Cross-Sectional Study among French General PractitionersSohela Moussaoui, Anne Marie Aurousseau, Sylvain Nappez, et al.
Antiviral Therapy|November 18, 2009
A population analysis of weight-related differences in lopinavir pharmacokinetics and possible consequences for protease inhibitor-naive and -experienced patientsMarion Bouillon-Pichault, Vincent Jullien, Christophe Piketty, et al.
Influenza and Other Respiratory Viruses|November 17, 2025
Relative Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccines in Preventing Hospitalizations: A National Retrospective Cohort Study in France, 2022/2023 SeasonHélène Bricout, Marie-Cécile Levant, Pascal Crépey, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2024
The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-2022 influenza seasonHélène Bricout, Marie-Cécile Levant, Nada Assi, et al.
The Journal of Clinical Investigation|March 8, 2019
Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccinationEléna Gonçalves, Olivia Bonduelle, Angèle Soria, et al.
Human Vaccines|February 18, 2009
Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendationsOdile Launay, Christine Toneatti, Claire Bernède, et al.
Arthritis Care & Research|April 5, 2013
Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort studySolen Kernéis, Odile Launay, Thierry Ancelle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2021
Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?Caroline Papeix, Julie Mazoyer, Elisabeth Maillart, et al.
Pageof 31